Title: Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients
Goals resulting from providing support to young breast cancer survivors and metastatic breast cancer patients include: increased support for caregivers and families for these individuals, increased awareness of clinical trials by both young women diagnosed with cancer and individuals diagnosed with metastic breast cancer, increased financial support, and improved quality of life among young breast cancer survivors.
General information about this opportunity
Last Known Status
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Statute Patient Protection and Affordable Care Act (PPACA), SEC. 399NN. YOUNG WOMEN’S BREAST HEALTH AWARENESS AND SUPPORT OF YOUNG WOMEN DIAGNOSED WITH BREAST CANCER,
This statute amends the US Public Health Service Act, which allows for the provision of: (1) campaigns to educate the public and health care professionals about young women's breast health, (2) research that explores strategies to prevent breast cancer in young women, and (3) support for young women with breast cancer.
Who is eligible to apply/benefit from this assistance?
Government organizations, non-governmental organizations, private colleges and universities, community-based organizations, faith-based organizations, for-profit organizations (other than small business), and small businesses can apply.
What is the process for applying and being award this assistance?
Preapplication coordination is not applicable.
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
Review and Selection Process: Applications will be reviewed in three phases. Phase I Review: applications will be reviewed initially for completeness by CDC OGS staff and will be reviewed jointly for eligibility by the CDC NCCDPHP DCPC and OGS. Phase II Review: A review panel will evaluate complete, eligible applications in accordance with the "Criteria" section of the NOFO. Phase III Review: Applications will be funded in order by score and rank determined by the review panel.
From May 1, 2019 to July 1, 2019 Letter of Intent due June 3, 2019
Approval/Disapproval Decision Time
From 120 to 180 days. n/a
From 120 to 180 days. n/a
From 120 to 180 days. Upon availability of funds and/or successful performance, CDC/OFR will provide instructions on renewal and/or continuation during each budget year of the project.
How are proposals selected?
How may assistance be used?
Due Date for Applications: TBD, 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.
What are the requirements after being awarded this opportunity?
Awardee Evaluation and Performance Measurement Plan:
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
9/30/2019 – 9/29/2024
Who do I contact about this opportunity?
Regional or Local Office
Centers for Disease Prevention and Control (CDC) Division of Cancer Prevention and Control (DCPC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)
Angela R. Moore, MPH
4770 Buford Highway
Chamblee Campus, Building 107/4th Floor
Atlanta, GA 30341 USA
(Cooperative Agreements (Discretionary Grants)) FY 18$0.00; FY 19 est $1,800,000.00; FY 20 est $1,800,000.00; FY 17 - This number supports a new FY19 NOFO period of performance to begin 9/2019
Range and Average of Financial Assistance
150000 -- 350000
Regulations, Guidelines and Literature